A carregar...
EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) has entered the age of individual treatment, and increasing point mutations of specific oncogenes and rearrangement of some chromosomes are biomarkers used to predict the therapeutic effect of targeted therapy. At present, there is a consensus among clinicians that...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4189714/ https://ncbi.nlm.nih.gov/pubmed/25302015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S69690 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|